Dupont Capital Management Corp Staar Surgical CO Transaction History

Dupont Capital Management Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$46.82 - $76.2 $176,745 - $287,655	-3,775 Reduced 48.92%	3,941 $0
Q3 2022 Oct 31, 2022	SELL	$70.55 - $111.58 $145,474 - $230,077	-2,062 Reduced 21.09%	7,716 $544,000
Q2 2022 Jul 26, 2022	BUY	$50.24 - $80.48 $54,862 - $87,884	1,092 Added 12.57%	9,778 $694,000
Q1 2022 Apr 27, 2022	BUY	$57.98 - $93.5 $382,899 - $617,474	6,604 Added 317.2%	8,686 $694,000
Q4 2021 Jan 31, 2022	SELL	$88.02 - $127.79 $131,677 - $191,173	-1,496 Reduced 41.81%	2,082 $190,000
Q3 2021 Nov 03, 2021	BUY	$122.75 - $162.68 $31,055 - $41,158	253 Added 7.61%	3,578 $460,000
Q1 2021 Apr 29, 2021	SELL	$78.5 - $126.48 $53,615 - $86,385	-683 Reduced 17.04%	3,325 $350,000
Q4 2020 Jan 28, 2021	SELL	$55.93 - $82.78 $287,592 - $425,654	-5,142 Reduced 56.2%	4,008 $318,000
Q3 2020 Oct 29, 2020	SELL	$45.65 - $61.81 $27,983 - $37,889	-613 Reduced 6.28%	9,150 $518,000
Q2 2020 Jul 24, 2020	BUY	$29.15 - $61.54 $284,591 - $600,815	9,763 New	9,763 $601,000

255

47.8M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.35B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.